Dr. Victor Shi, President, Qiagen Asia

Headquartered in Germany, Qiagen is a global leading provider of sample and assay technologies. And President Victor Shi of Qiagen Asia shared with the audience his views about global cooperation.

"Molecular diagnosis plays an increasingly important role in the general trend of customized medical services. This is a challenge and an opportunity as well, which requires closer partnership between diagnosis company and drug developer. We're now working with the market leaders on developing dozens of new drugs."

"Positioning and pricing, these are two secrets of our success," he summarized. "We have detailed and constantly-improved plans on market analysis, strategic development, targeting customers, and marketing channels. Since pricing is an uncertain factor and has great impact on multinational companies, a successful business must be based on the calculated balance between two pricing systems decided by the government and the market."

Qiagen Asia plans to focus on R&D and products and to create a mutually beneficial cooperation network with more partners. "Qiagen Suzhou Translational Medicine Center is a project we invested together with BioBay and we will explore marketing and training with colleges and other business partners. With win-win cooperation, we double the results with half effort in expanding business scope."